The yellow fever 17D vaccine and risk of malignant melanoma in the United States military

Highlights ► We assessed the association between YF 17D and risk of malignant melanoma. ► Population included active US military personnel who received any vaccine. ► No association was found between YF 17D and risk of malignant melanoma in military in the 10 years following vaccination.

Saved in:
Bibliographic Details
Published in:Vaccine 2012-06, Vol.30 (30), p.4476-4479
Main Authors: Hodges-Vazquez, Meredith, Wilson, James P, Hughes, Hayley, Garman, Patrick
Format: Article
Language:English
Subjects:
Adult
Allergy and Immunology
Antigen (tumor-associated)
antigens
Case-Control Studies
Female
Homology
Humans
Logistic Models
Male
Melanoma
Melanoma - epidemiology
Military
Military Personnel
monitoring
Mycobacterium
Nested case–control study
protective effect
risk
Risk Factors
Skin cancer
Smallpox
Studies
Tuberculosis
United States
Vaccination
Vaccines
Vector-borne diseases
Yellow fever
Yellow fever vaccine
Yellow Fever Vaccine - administration & dosage
Yellow fever virus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► We assessed the association between YF 17D and risk of malignant melanoma. ► Population included active US military personnel who received any vaccine. ► No association was found between YF 17D and risk of malignant melanoma in military in the 10 years following vaccination.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.04.074